|CRDAMC Homepage | CRDAMC Library Phone #: (254) 288-8366 | CRDAMC Library Fax #: (254) 288-8368|
June 01, 2014
New Approach May Boost Survival From Advanced Prostate Cancer
SUNDAY, June 1, 2014 (HealthDay News) -- Adding the chemotherapy drug docetaxel to standard hormone-depleting therapy may extend the lives of men with advanced prostate cancer, a new study finds.
Number of Cancer Survivors Should Grow to 19 Million in Next Decade: Report
SUNDAY, June 1, 2014 (HealthDay News) -- The number of cancer survivors in the United States will rise from the current 14.5 million to nearly 19 million by 2024, a new report predicts.
Newer Anti-Estrogen Treatment May Benefit Younger Breast Cancer Survivors
SUNDAY, June 1, 2014 (HealthDay News) -- A new type of anti-estrogen drug appears to work better than the estrogen-blocking drug tamoxifen in preventing recurrences of breast cancer in certain women, a new study reports.
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.
To send comments or feedback to our Editorial Team regarding the content please email us at email@example.com. Our Health Library Support team will respond to your email request within 2 business days.